Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
Actinium Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 810K | 810K | 810K | 81K | 81K | 81K | 81K | 114K | 159K | 204K | 1.14M | 1.05M | 1.24M | 1.46M | 1.14M | 1.12M | 888K | 622K |
Cost of Revenue | 611K | 596K | 607K | 806K | 804K | 824K | 608K | 570K | 591K | 562K | 699K | 675K | 454K | 274K | 137K | n/a | n/a | n/a |
Gross Profit | -206K | -191K | -202K | -725K | -723K | -743K | -527K | -456K | -432K | -358K | 445K | 378K | 787K | 1.19M | 1.01M | 1.12M | 888K | 622K |
Operating Income | -44.25M | -49.16M | -42.12M | -44.96M | -46.71M | -49.93M | -51.92M | -52.87M | -48.32M | -40.52M | -34.1M | -30.86M | -27.53M | -24.76M | -24.96M | -23.35M | -22.5M | -22.08M |
Interest Income | 3.21M | 3.65M | 3.88M | 4.04M | 4.09M | 3.48M | 3.1M | 2.73M | 1.98M | 1.6M | 1.09M | 481K | 202K | 173K | 190K | 207K | 234K | 217K |
Pretax Income | -41.04M | -45.51M | -38.24M | -40.91M | -42.62M | -46.45M | -48.82M | -50.14M | -46.34M | -38.92M | -33.02M | -30.38M | -27.33M | -24.58M | -24.77M | -23.14M | -22.26M | -21.86M |
Net Income | -41.04M | -45.51M | -38.24M | -40.91M | -42.62M | -46.45M | -48.82M | -49.5M | -45.37M | -37.96M | -32.01M | -30.02M | -27.29M | -24.55M | -24.77M | -23.14M | -22.26M | -21.86M |
Selling & General & Admin | 17.08M | 18.05M | 12.08M | 11.69M | 11.59M | 12.56M | 13.33M | 14.98M | 15.33M | 14M | 12M | 10.7M | 9.62M | 8.09M | 8.08M | 7.22M | 7.05M | 6.49M |
Research & Development | 27.16M | 31.11M | 29.83M | 32.94M | 34.78M | 37.04M | 38.47M | 37.88M | 33.03M | 26.61M | 23.14M | 21.22M | 19.16M | 18.12M | 18.03M | 17.25M | 16.33M | 16.21M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 44.25M | 49.16M | 41.91M | 44.63M | 46.38M | 49.6M | 51.8M | 52.87M | 48.36M | 40.61M | 35.13M | 31.91M | 28.77M | 26.22M | 26.11M | 24.47M | 23.38M | 22.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 44.25M | 49.16M | 42.12M | 45.04M | 46.79M | 50.01M | 52M | 52.87M | 48.36M | 40.61M | 35.13M | 31.91M | 28.77M | 26.22M | 26.11M | 24.47M | 23.38M | 22.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 86.92K | 86.92K | -557.09K | -882.09K | -969K | -1M | -360K | -35K | -35K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 24.93M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M | 18.38M |
Shares Outstanding (Diluted) | 31.2M | 31.2M | 31.2M | 31.07M | 30.1M | 27.89M | 27.63M | 27.06M | 26.22M | 25.7M | 25.68M | 25.16M | 23.73M | 22.14M | 21.54M | 21.54M | 20.23M | 18.38M |
EPS (Basic) | -1.31 | -1.47 | -1.27 | -1.4 | -1.52 | -1.72 | -1.84 | -1.89 | -1.77 | -1.52 | -1.32 | -1.3 | -1.23 | -1.15 | -1.21 | -1.19 | -1.25 | -1.41 |
EPS (Diluted) | -1.31 | -1.47 | -1.27 | -1.4 | -1.52 | -1.72 | -1.84 | -1.89 | -1.76 | -1.51 | -1.31 | -1.29 | -1.23 | -1.15 | -1.21 | -1.19 | -1.25 | -1.41 |
EBITDA | -43.84M | -48.57M | -41.31M | -44.15M | -45.91M | -49.11M | -51.13M | -52.12M | -47.54M | -39.78M | -33.41M | -30.19M | -26.94M | -24.22M | -24.44M | -22.84M | -22.01M | -21.62M |
EBIT | -42.92M | -48.46M | -42.12M | -44.96M | -46.71M | -49.93M | -51.92M | -52.87M | -48.32M | -40.52M | -34.1M | -30.86M | -27.53M | -24.76M | -24.96M | -23.35M | -22.5M | -22.08M |
Depreciation & Amortization | 611K | 800K | 811K | 806K | 804K | 824K | 790K | 752K | 773K | 744K | 699K | 675K | 587K | 536K | 524K | 507K | 485K | 464K |